S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
OTCMKTS:TRSSF

TerrAscend - TRSSF Stock Forecast, Price & News

$1.40
-0.03 (-2.10%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.37
$1.46
50-Day Range
$1.21
$1.81
52-Week Range
$1.00
$6.06
Volume
127,242 shs
Average Volume
246,677 shs
Market Capitalization
$352.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.19

TerrAscend MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
128.0% Upside
$3.19 Price Target
Short Interest
Healthy
0.20% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.30mentions of TerrAscend in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars


TRSSF stock logo

About TerrAscend (OTCMKTS:TRSSF) Stock

TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.

Receive TRSSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter.

TRSSF Stock News Headlines

Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
TerrAscend (TRSSF) to Release Earnings on Thursday
Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
TerrAscend Launches Gage Cannabis In Maryland
TerrAscend Reduces Outstanding Debt By $30M
TerrAscend Reduces Outstanding Debt by US$30 Million
TerrAscend Reports Third Quarter 2022 Financial Results
See More Headlines
Receive TRSSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter.

TRSSF Company Calendar

Last Earnings
11/16/2021
Today
3/22/2023
Next Earnings (Estimated)
5/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Agricultural production - crops
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRSSF
Fax
N/A
Employees
742
Year Founded
2017

Price Target and Rating

Average Stock Price Forecast
$3.19
High Stock Price Forecast
$4.50
Low Stock Price Forecast
$1.75
Forecasted Upside/Downside
+128.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
$-329,910,000.00
Net Margins
-132.22%
Pretax Margin
-125.16%

Debt

Sales & Book Value

Annual Sales
$247.83 million
Book Value
$1.28 per share

Miscellaneous

Free Float
140,237,000
Market Cap
$352.60 million
Optionable
Not Optionable
Beta
N/A

Social Links


Key Executives

  • Ziad Ghanem
    President & Chief Operating Officer
  • Keith Stauffer
    Chief Financial Officer
  • David Wheeler
    Chief Information Officer & Senior Vice President
  • Daniel Foley
    Treasurer & Senior Vice President
  • Jared Anderson
    Senior Vice President-Finance & Strategy













TRSSF Stock - Frequently Asked Questions

Should I buy or sell TerrAscend stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TRSSF shares.
View TRSSF analyst ratings
or view top-rated stocks.

What is TerrAscend's stock price forecast for 2023?

6 equities research analysts have issued 12-month price targets for TerrAscend's stock. Their TRSSF share price forecasts range from $1.75 to $4.50. On average, they predict the company's share price to reach $3.19 in the next year. This suggests a possible upside of 128.0% from the stock's current price.
View analysts price targets for TRSSF
or view top-rated stocks among Wall Street analysts.

How have TRSSF shares performed in 2023?

TerrAscend's stock was trading at $1.13 at the start of the year. Since then, TRSSF stock has increased by 23.9% and is now trading at $1.40.
View the best growth stocks for 2023 here
.

When is TerrAscend's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our TRSSF earnings forecast
.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TRSSF) posted its quarterly earnings results on Tuesday, November, 16th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.29. TerrAscend had a negative trailing twelve-month return on equity of 2.66% and a negative net margin of 132.22%.

What is TerrAscend's stock symbol?

TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF."

How do I buy shares of TerrAscend?

Shares of TRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TerrAscend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $1.40.

How much money does TerrAscend make?

TerrAscend (OTCMKTS:TRSSF) has a market capitalization of $352.60 million and generates $247.83 million in revenue each year. The company earns $-329,910,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis.

How many employees does TerrAscend have?

The company employs 742 workers across the globe.

How can I contact TerrAscend?

TerrAscend's mailing address is PO Box 43125, Mississauga, ON L5B. The official website for the company is www.terrascend.com. The company can be reached via phone at (855) 837-7295 or via email at ir@terrascend.com.

This page (OTCMKTS:TRSSF) was last updated on 3/22/2023 by MarketBeat.com Staff